Published quarterly, Genomic Medicine will appear in both electronic and print formats. Fast publication in Online First will make the journal accessible and searchable within the framework of SpringerLink, Springer's premier electronic information platform. All original papers and articles submitted to Genomic Medicine will be assessed through a rigorous peer-review process, keeping in line with other leading international biomedical journals. In addition, all potential authors have the option, via the Springer Open Choice program, of publishing their articles using the open access publishing model once they have been accepted for publication. The first issue is scheduled for March 2007.
Springer is the second-largest publisher worldwide in the science, technology, and medicine (STM) sector. Springer is part of Springer Science+Business Media, one of the world's leading suppliers of scientific and specialist literature. The group owns 70 publishing houses, together publishing a total of 1,450 journals and more than 5,000 new books a year. The group operates in over 20 countries in Europe, the USA, and Asia, and has some 5,000 employees. In 2005, it generated annual sales of around EUR 838 million.